ScreenerHero

BGLC BioNexus Gene Lab Corp.

NAS · US · Basic Materials · Specialty Chemicals · bionexusgenelab.com
1.240USD-3.13%Mkt Cap: 3.64M $P/E: —

BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malay…

Industry Peers

Specialty Chemicals
Screen all
LIN
Linde plc
$225.86BUSDP/E 31.6
LIN
Linde plc
$210.90BUSDP/E 29.5
AI
L'Air Liquide S.A.
$117.30BUSDP/E 30.5
ECL
Ecolab Inc.
$78.72BUSDP/E 37.7
SHW
The Sherwin-Williams Company
$77.96BUSDP/E 29.6
APD
Air Products and Chemicals, Inc.
$62.57BUSD
GIVN
Givaudan SA
$35.84BUSDP/E 33.1
SIKA
Sika AG
$32.14BUSDP/E 27.1
DSFIR
DSM-Firmenich AG
$26.46BUSD
PPG
PPG Industries, Inc.
$23.68BUSDP/E 15.3
EMSN
EMS-CHEMIE HOLDING AG
$22.34BUSDP/E 41.3
IFF
International Flavors & Fragrances Inc.
$21.43BUSDP/E 83.1
LYB
LyondellBasell Industries N.V.
$19.04BUSD
SQM
Sociedad Química y Minera de Chile S.A.
$18.90BUSDP/E 13.6
DD
DuPont de Nemours, Inc.
$18.00BUSDP/E 35.8
SY1
Symrise AG
$13.68BUSDP/E 51.8
ALB
Albemarle Corporation
$12.55BUSDP/E 393.9
RPM
RPM International Inc.
$12.54BUSDP/E 19.0
AKZA
Akzo Nobel N.V.
$10.95BUSDP/E 16.1
EVK
Evonik Industries AG
$10.53BUSDP/E 79.9

Key Statistics

Company
Market Cap3.64M USD
Enterprise Value439.13K USD
Revenue (TTM)3.13M USD
Gross Profit1.09M USD
Net Income (TTM)-2.98M USD
Revenue/Share1.44 USD
Last Price1.240 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees19
CountryUS
SectorBasic Materials
IndustrySpecialty Chemicals
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.17
EV/Revenue0.14
P/S1.16
P/B0.39
EPS (TTM)-1.26
EPS (Forward)—
52W Range
1.0703% of range5.930
52W High5.930 USD
52W Low1.070 USD
Profitability
Gross Margin14.62%
Oper. Margin-398.69%
EBITDA Margin-84.44%
Profit Margin-40.20%
ROE-34.64%
ROA-32.26%
Growth
Revenue Growth-96.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.84M USD
CapEx (TTM)36.97K USD
FCF Margin2.18%
FCF Yield1.88%
Net Debt-3.20M USD
Net Debt/EBITDA1.21
Balance Sheet
Debt/Equity0.02
Current Ratio6.08
Quick Ratio4.56
Book Value/Sh3.22 USD
Cash/Share1.20 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateApr 7, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.93M
Float1.67M
Insiders44.72%
Institutions0.49%
Short Interest
Short Ratio1.5d
Short % Float0.51%
Short % Out.0.44%
Shares Short13.03K
Short (prev mo.)7.31K
Technical
SMA 501.467 (-15.5%)
SMA 2002.227 (-44.3%)
Beta2.20
S&P 52W Chg16.45%
Avg Vol (30d)10.44K
Avg Vol (10d)10.47K
Technical Indicators
RSI (14)37.7
MACD-0.0805
MACD Signal-0.0650
MACD Hist.-0.0156
BB Upper1.641 USD
BB Middle1.399 USD
BB Lower1.157 USD
BB Width34.53%
ATR (14)0.1092 USD
Vol Ratio (20d)2.29x